Camp4 Therapeutics Corp
Ticker: 1736730
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY2026 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q3 FY2023 |
|---|---|---|---|---|---|
| INCOME | |||||
| Revenue | 1.29+61.2% | 0.80-46.7% | 1.50+74.4% | 0.86+145.7% | 0.35 |
| Total Income | 1.29+61.2% | 0.80-46.7% | 1.50+74.4% | 0.86+145.7% | 0.35 |
| EXPENSES | |||||
| Expenditure | 14.37-0.6% | 14.45-0.6% | 14.53+4.1% | 13.96+10.0% | 12.69 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PROFIT | |||||
| Net Profit | -18.33-21.4% | -15.10-19.9% | -12.59-1.3% | -12.43-6.2% | -11.70 |
| KEY METRICS | |||||
| OPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| NPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| EPS | -0.32+41.8% | -0.55+11.3% | -0.62+0.0% | -0.62+97.9% | -29.21 |
Corporate Events
Board MeetingCAMP
202610Jun
Board Meeting
Annual Meeting of stockholders to elect Class II directors, …
SEC Filing ↗